• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

PRMT3通过增加染色质可及性来逆转HIV-1潜伏状态,以形成一个包含TEAD4-P-TEFb的转录枢纽。

PRMT3 reverses HIV-1 latency by increasing chromatin accessibility to form a TEAD4-P-TEFb-containing transcriptional hub.

作者信息

Wang Xinyu, Xue Yuhua, Li Lin, Song Jinwen, Jia Lei, Li Xu, Fan Miao, Lu Lu, Su Wen, Han Jingwan, Lin Dandan, Liu Rongdiao, Gao Xiang, Guo Yafei, Xiang Zixun, Chen Chunjing, Wan Linyu, Chong Huihui, He Yuxian, Wang Fusheng, Yao Kaihu, Zhou Qiang, Yu Dan

机构信息

Laboratory of Infection and Microbiology, Beijing Pediatric Research Institute, Beijing Children's Hospital, Capital Medical University, Key Laboratory of Major Diseases in Children, Ministry of Education, National Center for Children's Health, Beijing, China.

State Key Laboratory of Vaccines for Infectious Diseases, Fujian Provincial Key Laboratory of Innovative Drug Target Research, School of Pharmaceutical Sciences, Xiang An Biomedicine Laboratory, Affiliated Xiamen Eye Center, Xiamen University, Xiamen, China.

出版信息

Nat Commun. 2025 May 15;16(1):4529. doi: 10.1038/s41467-025-59578-5.

DOI:10.1038/s41467-025-59578-5
PMID:40374607
原文链接:
https://pmc.ncbi.nlm.nih.gov/articles/PMC12081701/
Abstract

Latent HIV-1 presents a formidable challenge for viral eradication. HIV-1 transcription and latency reversal require interactions between the viral promoter and host proteins. Here, we perform the dCas9-targeted locus-specific protein analysis and discover the interaction of human arginine methyltransferase 3 (PRMT3) with the HIV-1 promoter. This interaction reverses latency in cell line models and primary cells from latently infected persons by increasing the levels of H4R3Me2a and transcription factor P-TEFb at the viral promoter. PRMT3 is found to promote chromatin accessibility and transcription of HIV-1 and a small subset of host genes in regions harboring the classical recognition motif for another transcription factor TEAD4. This motif attracts TEAD4 and PRMT3 to the viral promoter to synergistically activate transcription. Physical interactions among PRMT3, P-TEFb, and TEAD4 exist, which may help form a transcriptional hub at the viral promoter. Our study reveals the potential of targeting these hub proteins to eradicate latent HIV-1.

摘要

潜伏的HIV-1对病毒根除构成了巨大挑战。HIV-1转录和潜伏期逆转需要病毒启动子与宿主蛋白之间的相互作用。在这里,我们进行了dCas9靶向的位点特异性蛋白质分析,并发现了人类精氨酸甲基转移酶3(PRMT3)与HIV-1启动子的相互作用。这种相互作用通过增加病毒启动子处H4R3Me2a和转录因子P-TEFb的水平,逆转了细胞系模型和潜伏感染个体原代细胞中的潜伏期。发现PRMT3可促进HIV-1以及另一个转录因子TEAD4的经典识别基序所在区域中一小部分宿主基因的染色质可及性和转录。该基序将TEAD4和PRMT3吸引到病毒启动子上,协同激活转录。PRMT3、P-TEFb和TEAD4之间存在物理相互作用,这可能有助于在病毒启动子处形成转录中心。我们的研究揭示了靶向这些中心蛋白以根除潜伏HIV-1的潜力。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/12081701/5a0a4e32b414/41467_2025_59578_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/12081701/a695df2bed04/41467_2025_59578_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/12081701/309c88a00300/41467_2025_59578_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/12081701/d2c6750697e9/41467_2025_59578_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/12081701/0c0b8caec496/41467_2025_59578_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/12081701/2e67086bceb9/41467_2025_59578_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/12081701/60d9f5cbeb7f/41467_2025_59578_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/12081701/5a0a4e32b414/41467_2025_59578_Fig7_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/12081701/a695df2bed04/41467_2025_59578_Fig1_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/12081701/309c88a00300/41467_2025_59578_Fig2_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/12081701/d2c6750697e9/41467_2025_59578_Fig3_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/12081701/0c0b8caec496/41467_2025_59578_Fig4_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/12081701/2e67086bceb9/41467_2025_59578_Fig5_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/12081701/60d9f5cbeb7f/41467_2025_59578_Fig6_HTML.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/36a8/12081701/5a0a4e32b414/41467_2025_59578_Fig7_HTML.jpg

相似文献

1
PRMT3 reverses HIV-1 latency by increasing chromatin accessibility to form a TEAD4-P-TEFb-containing transcriptional hub.PRMT3通过增加染色质可及性来逆转HIV-1潜伏状态,以形成一个包含TEAD4-P-TEFb的转录枢纽。
Nat Commun. 2025 May 15;16(1):4529. doi: 10.1038/s41467-025-59578-5.
2
FACT Proteins, SUPT16H and SSRP1, Are Transcriptional Suppressors of HIV-1 and HTLV-1 That Facilitate Viral Latency.FACT蛋白、SUPT16H和SSRP1是HIV-1和HTLV-1的转录抑制因子,可促进病毒潜伏。
J Biol Chem. 2015 Nov 6;290(45):27297-27310. doi: 10.1074/jbc.M115.652339. Epub 2015 Sep 16.
3
TRIM28 promotes HIV-1 latency by SUMOylating CDK9 and inhibiting P-TEFb.TRIM28 通过 SUMOylation 修饰 CDK9 并抑制 P-TEFb 来促进 HIV-1 潜伏。
Elife. 2019 Jan 17;8:e42426. doi: 10.7554/eLife.42426.
4
The KAT5-Acetyl-Histone4-Brd4 axis silences HIV-1 transcription and promotes viral latency.KAT5-乙酰化组蛋白 4-Brd4 轴沉默 HIV-1 转录并促进病毒潜伏。
PLoS Pathog. 2018 Apr 23;14(4):e1007012. doi: 10.1371/journal.ppat.1007012. eCollection 2018 Apr.
5
BET bromodomain-targeting compounds reactivate HIV from latency via a Tat-independent mechanism.BET 溴结构域靶向化合物通过一种不依赖 Tat 的机制重新激活潜伏状态的 HIV。
Cell Cycle. 2013 Feb 1;12(3):452-62. doi: 10.4161/cc.23309. Epub 2012 Feb 1.
6
A Two-Color Haploid Genetic Screen Identifies Novel Host Factors Involved in HIV-1 Latency.双色单倍体遗传筛选鉴定新型 HIV-1 潜伏期相关宿主因子。
mBio. 2021 Dec 21;12(6):e0298021. doi: 10.1128/mBio.02980-21. Epub 2021 Dec 7.
7
BET degraders reveal BRD4 disruption of 7SK and P-TEFb is critical for effective reactivation of latent HIV in CD4+ T-cells.BET降解剂揭示BRD4对7SK和P-TEFb的破坏对于CD4 + T细胞中潜伏HIV的有效重新激活至关重要。
J Virol. 2025 Apr 15;99(4):e0177724. doi: 10.1128/jvi.01777-24. Epub 2025 Mar 11.
8
UHRF1 Suppresses HIV-1 Transcription and Promotes HIV-1 Latency by Competing with p-TEFb for Ubiquitination-Proteasomal Degradation of Tat.UHRF1 通过与 p-TEFb 竞争泛素化-蛋白酶体降解 Tat 来抑制 HIV-1 转录并促进 HIV-1 潜伏期。
mBio. 2021 Aug 31;12(4):e0162521. doi: 10.1128/mBio.01625-21.
9
Release of P-TEFb from the Super Elongation Complex promotes HIV-1 latency reversal.P-TEFb 从超延伸复合物中的释放促进 HIV-1 潜伏期逆转。
PLoS Pathog. 2024 Sep 11;20(9):e1012083. doi: 10.1371/journal.ppat.1012083. eCollection 2024 Sep.
10
SUN2 Modulates HIV-1 Infection and Latency through Association with Lamin A/C To Maintain the Repressive Chromatin.SUN2 通过与核纤层蛋白 A/C 结合来维持抑制性染色质,从而调节 HIV-1 感染和潜伏期。
mBio. 2018 May 1;9(3):e02408-17. doi: 10.1128/mBio.02408-17.

本文引用的文献

1
CBP/p300 lysine acetyltransferases inhibit HIV-1 expression in latently infected T cells.CBP/p300赖氨酸乙酰转移酶抑制潜伏感染T细胞中的HIV-1表达。
iScience. 2024 Oct 28;27(12):111244. doi: 10.1016/j.isci.2024.111244. eCollection 2024 Dec 20.
2
KDM5A/B contribute to HIV-1 latent infection and survival of HIV-1 infected cells.KDM5A/B 有助于 HIV-1 潜伏感染和 HIV-1 感染细胞的存活。
Antiviral Res. 2024 Aug;228:105947. doi: 10.1016/j.antiviral.2024.105947. Epub 2024 Jun 24.
3
RPLP1 restricts HIV-1 transcription by disrupting C/EBPβ binding to the LTR.
RPLP1 通过破坏 C/EBPβ 与 LTR 的结合来限制 HIV-1 的转录。
Nat Commun. 2024 Jun 21;15(1):5290. doi: 10.1038/s41467-024-49622-1.
4
Structural rearrangements in the nucleus localize latent HIV proviruses to a perinucleolar compartment supportive of reactivation.核内结构重排将潜伏的 HIV 前病毒定位到支持重新激活的核周腔室。
Proc Natl Acad Sci U S A. 2024 Apr 30;121(18):e2202003121. doi: 10.1073/pnas.2202003121. Epub 2024 Apr 26.
5
PCID2 dysregulates transcription and viral RNA processing to promote HIV-1 latency.PCID2失调转录和病毒RNA加工以促进HIV-1潜伏。
iScience. 2024 Feb 6;27(3):109152. doi: 10.1016/j.isci.2024.109152. eCollection 2024 Mar 15.
6
Selection of epigenetically privileged HIV-1 proviruses during treatment with panobinostat and interferon-α2a.在泛昔洛韦和干扰素-α2a 治疗过程中选择受表观遗传调控的 HIV-1 前病毒。
Cell. 2024 Feb 29;187(5):1238-1254.e14. doi: 10.1016/j.cell.2024.01.037. Epub 2024 Feb 17.
7
Enhanced NF-κB activation via HIV-1 Tat-TRAF6 cross-talk.通过 HIV-1 Tat-TRAF6 相互作用增强 NF-κB 激活。
Sci Adv. 2024 Jan 19;10(3):eadi4162. doi: 10.1126/sciadv.adi4162.
8
PRMT3-Mediated Arginine Methylation of METTL14 Promotes Malignant Progression and Treatment Resistance in Endometrial Carcinoma.PRMT3 介导的 METTL14 精氨酸甲基化促进子宫内膜癌的恶性进展和治疗抵抗。
Adv Sci (Weinh). 2023 Dec;10(36):e2303812. doi: 10.1002/advs.202303812. Epub 2023 Nov 16.
9
PRMT2 promotes HIV-1 latency by preventing nucleolar exit and phase separation of Tat into the Super Elongation Complex.PRMT2 通过防止核仁出口和 Tat 进入超级延伸复合物的相分离来促进 HIV-1 潜伏期。
Nat Commun. 2023 Nov 10;14(1):7274. doi: 10.1038/s41467-023-43060-1.
10
Comprehensive synergy mapping links a BAF- and NSL-containing "supercomplex" to the transcriptional silencing of HIV-1.全面的协同作用图谱将一个包含BAF和NSL的“超级复合物”与HIV-1的转录沉默联系起来。
Cell Rep. 2023 Sep 26;42(9):113055. doi: 10.1016/j.celrep.2023.113055. Epub 2023 Sep 7.